Breast Cancer Clinical Trial
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
The objective of this project is to validate a next-generation assay that utilizes both the protein biomarkers of our already established ovarian cancer risk assessment combined with a molecular profile in both germline and early somatic detection.
Key inclusion criteria:
18 years of age or older
Cohort A specific inclusion criteria:
• Diagnosed with a pelvic mass
Cohort B specific inclusion criteria:
Diagnosed with a pelvic mass
Undergoing genetic testing through our commercial offering
Cohort C specific inclusion criteria:
• Subject must not have an identifiable adnexal mass and may, or may not, have a family history or a known familial genetic abnormality (germ line or identified in family cancer i.e. somatic DNA mutation) associated with ovarian cancer.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Austin Texas, 78738, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.